Grand River Aseptic Manufacturing Announces $100 Million Investment in Sterile Manufacturing Capabilities
The company is enhancing its U.S. sterile fill-finish contract manufacturing services to meet growing industry demand for prefilled syringes and…
CEO Insights and Trends: The Future of the Sterile Filling CDMO Industry
Denis Johnson, CEO, explores developments in the CDMO sector and reveals how GRAM is gearing up for its latest phase…
Harnessing the Power of CDMOs in Modern Drug Development
Change is constant in the pharmaceutical industry, and companies must keep pace with regulatory requirements, technological advancements, and patient expectations….
Executives from GRAM and LTS Discuss Qualities of a CDMO Redefining Innovation
What are the traits that redefine innovation in fill-finish partners? GRAM’s CEO and LTS device leadership come together to discuss…
Embracing a Proactive Approach: What it Takes to Offer Patient-Centric CDMO Solutions
In today’s world, where customization is essential, patients have a growing expectation for accessible and comfortable medication. We are witnessing…
Sterile Filling Readiness in the Drug Device Delivery Ecosystem with Bausch+Ströbel, SKAN, and GRAM
Behind the Curtain: Sterile Filling Readiness in the Drug Device Delivery Ecosystem Go behind the curtain as we delve into…
Enriching Sterile Fill-Finish Services
PharmaNetwork Article: June 2025 Issue Grand River Aseptic Manufacturing’s Patient-Centric Approach Aseptic manufacturing is a crucial aspect of the life…
Grand River Aseptic Manufacturing (GRAM) Appoints Denis Johnson as Chief Executive Officer
Grand River Aseptic Manufacturing (“GRAM” or the “Company”), a portfolio company of Arlington Capital Partners, today announced the promotion of…
On Demand: GRAM Endpoints Manufacturing Day Webinar
On Demand: Key Factors, Critical Insights, and Essential Expertise for Selecting a Cartridge-Based Drug Delivery Device The strategic partnership between…